| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3b643b6fbf3afb7e5b1ed130f9ca4bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7d9874311fec276552bcc3a7a14423e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a2fc41fc740615c782d82d32c4ba41b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43e792a6173f52940d29e95189cc2824
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e48282de1ac0d4a78403d373506d3b99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21b455e614755230974c1d19a37b0cb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2001-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17dfb493c4d134073c8d69558c61f5a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab8452c8a8936fde723e8e3039dfc5f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_512793684b4c00e86fe50e65d7b8cc9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83e86df3f7902eb39068f313c906cea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7da9053379c9e5a1a74c276dcc20115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68dccb2371ae450da9b1aaa519d3d097 |
| publicationDate |
2001-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0189281-A2 |
| titleOfInvention |
Tumor-associated antigen (b132), characterized by seq. id. no. 2 |
| abstract |
The invention relates to the tumor-associated antigen B132, to the immunogenic peptides derived therefrom and to the DNA molecules encoding the same. The invention further relates to the use thereof in the immunotherapy of cancer diseases and as a target molecule for chemotherapeutical intervention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7232682-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637305-B2 |
| priorityDate |
2000-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |